A JAMA Internal Medicine viewpoint warns that generative AI now performs broad clinical tasks yet remains largely unregulated. Current FDA SaMD frameworks cannot govern dynamic, general-purpose models. Experts propose a new licensure system-modeled on clinician licensing-with supervised training, ongoing evaluation, and clear liability to ensure accountability as clinical AI rapidly expands.